#1
PRAXPRAXIS PRECISION MEDICINES I
- Reported value
- $655.97M
- Portfolio weight
- 12.83%
Quarterly change: unchanged
Institutional 13F data
Perceptive Advisors LLC 13F
See 0 stock and ETF positions for Q1 2026, including 0 new or increased positions and 0 reductions or exits, with the original SEC filing. Put and call options are excluded.
Perceptive Advisors LLC 13F top holdings
Q1 2026 · 91 stock & ETF positions · Filed 2026-05-15 · Data updated 2026-06-09
Ranked by quarter-end stock and ETF value reported on Form 13F. Put and call options are excluded. These are not current market values or execution prices.
- Reported stock & ETF value
- $5.09B
- Top 10 concentration
- 51.6%
#2
CELCCELCUITY INC
- Reported value
- $356.94M
- Portfolio weight
- 6.98%
Quarterly change: unchanged
#3
ASNDASCENDIS PHARMA A/S
- Reported value
- $350.28M
- Portfolio weight
- 6.85%
Quarterly change: unchanged
#4
ROIVROIVANT SCIENCES LTD
- Reported value
- $229.51M
- Portfolio weight
- 4.49%
Quarterly change: unchanged
#5
CNTACENTESSA PHARMACEUTICALS PLC
- Reported value
- $208.88M
- Portfolio weight
- 4.09%
Quarterly change: unchanged
#6
RYTMRHYTHM PHARMACEUTICALS INC
- Reported value
- $206.45M
- Portfolio weight
- 4.04%
Quarterly change: unchanged
- Reported value
- $190.83M
- Portfolio weight
- 3.73%
Quarterly change: unchanged
#8
NUVLNUVALENT INC
- Reported value
- $161.92M
- Portfolio weight
- 3.17%
Quarterly change: unchanged
#9
EWTXEDGEWISE THERAPEUTICS INC
- Reported value
- $139.36M
- Portfolio weight
- 2.73%
Quarterly change: unchanged
#10
PTGXPROTAGONIST THERAPEUTICS INC
- Reported value
- $129.73M
- Portfolio weight
- 2.54%
Quarterly change: unchanged
#11
APGEAPOGEE THERAPEUTICS INC
- Reported value
- $129.65M
- Portfolio weight
- 2.54%
Quarterly change: unchanged
#12
TVTXTRAVERE THERAPEUTICS INC
- Reported value
- $123.08M
- Portfolio weight
- 2.41%
Quarterly change: unchanged
Latest 13F filing snapshot
- Reporting period
- 2026-03-31
- Filed
- —
- Stock & ETF positions
- 0
- New or increased
- 0
- Reduced or exited
- 0
- Unchanged
- 0
Counts cover unique stock and ETF positions and exclude put and call options, so they can differ from the SEC information-table row count. Form 13F reports quarter-end holdings and does not reveal every trade date or execution price.
View original SEC filings ↗Detailed changes for published stocks
2026-03-31 · SYRE · unchanged
- Shares
- 3,783,225
- Share change
- —
- Reported value
- $190,825,869
- Filed
- 2026-05-15